You are here

Ido Amit

multiple myeloma drug resistant cells
22.02.2021

From bedside to bench and back: Researchers reveal a genetic signature that could help overcome drug resistance in some of the most aggressive...

Sharing Science
27.11.2020

A postdoc talks about complicated research, living at the Institute and the joys of scientific outreach

Surprising Players in Acute Liver Failure Point to Potential Treatment
26.10.2020

Gut microbes and host cells jointly contribute to the progression of this mostly incurable disease

pregnant belly with mask on
30.07.2020

In a study in mice, the mother’s natural anti-viral proteins disrupted the development of neural circuits in the fetus

Tissue sample from triple-negative breast cancer, stained for the presence of cancer cells (red) and the two types of cancer-associated fibroblasts: pCAFs (magenta) and sCAFs (green). The nuclei of all cells are stained blue
23.07.2020

Supporting actors in cancer growth may help predict the course of the disease

Prof. Ido Amit
16.06.2020

Prof. Ido Amit is the recipient of the Michael Bruno Memorial Award from the Israel Institute for Advanced Studies at the Hebrew University of...

Prof. Ido Amit
15.12.2019

Prof. Ido Amit is the recipient of the Sanofi – Institut Pasteur 2019 Junior Award

Fellows in the group of Prof. Ido Amit
14.01.2019

An advanced method for investigating the activity of single cells could lead to better immunotherapy drugs

Amit
06.12.2018

Israeli scientists and physicians develop a new technology for profiling the unique genetic makeup of myeloma tumor cells that will allow better...

(l-r) Prof. Ido Amit and Prof. Amos Tanay
30.10.2017

Weizmann Institute scientists have been chosen to participate in the international project to map every cell in the human body

Pages